Three F.D.A. Advisers Resign Over Approval of Alzheimer's Drug June 10, 2021 000 per year a monthly infusion priced at $56 Aduhelm IFTTT NYT NYT > Business NYTimes The drug was approved this week despite weak evidence that it helps patients. +